Patent · US Active

Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines

US11826378B2 · kind B2 · utility

1Cited by

0References

17Claims

0Family size

Inventors

Carla KROH · Oestrich-Winkel, DE
Ingo Lang · Ingelheim am Rhein, DE
Horst Rose · Burgdorf, DE
Franziska ROESSNER · Brotterode, DE
Saskia KLEY · Appenheim, DE

Key dates

Filing date	Feb 16, 2021
Grant date	Nov 28, 2023
Priority date	—
Expiry date	Feb 16, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in feline animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.